Association of Hemostatic Blood Product Transfusion With Clinical Outcomes in Esophageal Variceal Bleeding

Key Points

• Clinical outcomes improve significantly following the transfusion of hemostatic products in patients with esophageal variceal bleeding.
• A key improvement includes a reduction in mortality rates, observed within a cohort of patients over a standard 30-day period.
• Observational analysis assessing transfusion impact on clinical outcomes in a hospital setting highlights important variations.
• Results imply that the strategic use of hemostatic products in esophageal variceal bleeding may lead to enhanced patient survival.